Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Evidence for Cytogenetic and Fluorescence in Situ Hybridization (FISH) Risk Stratification of Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies.

Prashant Kapoor, MD, Rafael Fonseca, MD, S. Vincent Rajkumar, MD, Shirshendu Sinha, MBBS, Morie A. Gertz, MD, A. Keith Stewart, MD, P. Leif Bergsagel, MD, Martha Q. Lacy, MD, David Dingli, M.D., PhD., Rhett P. Ketterling, MD, Robert Kyle, M.D., Philip R. Greipp, MD, Angela Dispenzieri, MD, Shaji Kumar, MD

Blood (2009) 114 (22): 1802.

https://doi.org/10.1182/blood.V114.22.1802.1802

Published: 2009

Journal Articles

Isolated Trisomy 8 in the Myelodysplastic Syndromes.

Naseema Gangat, MBBS, Patricia Greipp, DO, Curtis A Hanson, MD, James Hoyer, MD, Dong Chen, MD, PhD, Rhett P. Ketterling, MD, David Dingli, M.D., PhD.

Blood (2009) 114 (22): 2785.

https://doi.org/10.1182/blood.V114.22.2785.2785

Published: 2009

Journal Articles

A Risk Adapted Approach Utilizing Plerixafor in Autologous Peripheral Blood Stem Cell Mobilization.

Ivana Micallef, Stephen M Ansell, Francis Buadi, David Dingli, M.D., PhD., Angela Dispenzieri, Dennis Gastineau, Morie Gertz, Suzanne R. Hayman, MD, William Hogan, MD, David J Inwards, Patrick L Johnston, MD, PhD, Shaji Kumar, MD, Martha Q. Lacy, MD, Mark R. Litzow, MD, Luis Porrata, MD, Robert Wolf, PharmD, Teresa Miceli, Jeff Winters

Blood (2009) 114 (22): 3211.

https://doi.org/10.1182/blood.V114.22.3211.3211

Published: 2009

Journal Articles

Predicting Poor Peripheral Blood Stem Cell Mobilization in Multiple Myeloma (MM) Using Initial Peripheral CD34 Counts: Developing Target-Based Cut-Points for Early Intervention.

Shirshendu Sinha, MBBS, Dennis A. Gastineau, MD, William J. Hogan, MBBCh, Ivana N Micallef, MD, Francis K. Buadi, MD, David Dingli, M.D., PhD., Angela Dispenzieri, MD, Morie A. Gertz, MD, Carl Greiner, Suzzane Hayman, MD, David J. Inwards, MD, Patrick B. Johnston, MD.Ph.D, Martha Q. Lacy, MD, Mark R. Litzow, MD, Luis F. Porrata, MD, Jeffrey Winters, MD, Shaji Kumar, MD

Blood (2009) 114 (22): 3231.

https://doi.org/10.1182/blood.V114.22.3231.3231

Published: 2009

Journal Articles

Asymptomatic Amyloidosis at the Time of Diagnostic Bone Marrow Biopsy in Newly Diagnosed Patients with Multiple Myeloma and Smoldering Multiple Myeloma.

Sergio Siragusa, MD, William Morice, MD, PhD, Morie A Gertz, MD, Robert Kyle, M.D., Philip R. Greipp, MD, John A. Lust, MD, PhD, Thomas E Witzig, MD, Martha Q. Lacy, MD, Steven R. Zeldenrust, M.D.,Ph.D., S. Vincent Rajkumar, MD, Suzanne R. Hayman, MD, Francis Buadi, Stephen J. Russell, MD, PhD, Shaji Kumar, MD, David Dingli, M.D., PhD., Angela Dispenzieri

Blood (2009) 114 (22): 2803.

https://doi.org/10.1182/blood.V114.22.2803.2803

Published: 2009

Journal Articles

A Phase II Trial of Lenalidomide, Cyclophosphamide and Dexamethasone (RCD) in Patients with Light Chain Amyloidosis.

Shaji Kumar, MD, Suzanne R. Hayman, MD, Francis Buadi, MD, Jacob Allred, Kristina Laumann, Vivek Roy, MD, FACP, Martha Q. Lacy, MD, Morie A Gertz, MD, Kristin Detweiler, R.N., C.N.P, Ann Birgin, Leif Bergsagel, MD, David Dingli, M.D., PhD., Joseph R. Mikhael, MD, Craig B. Reeder, MD, A. Keith Stewart, MBChB, Steven R. Zeldenrust, M.D., Ph.D., S. Vincent Rajkumar, MD, Angela Dispenzieri, MD

Blood (2009) 114 (22): 3853.

https://doi.org/10.1182/blood.V114.22.3853.3853

Published: 2009

Journal Articles

Engineering VSV-IFN-NIS for the Treatment of Multiple Myeloma.

Shruthi Naik, Rebecca A. Nace, Elizabeth A. Hadac, David Dingli, M.D., PhD., Mark Federspiel, Glen N. Barber, Stephen J. Russell, MD, PhD

Blood (2009) 114 (22): 378.

https://doi.org/10.1182/blood.V114.22.378.378

Published: 2009

Journal Articles

Clinical Features and Treatment Response of Light Chain (AL) Amyloidosis Diagnosed in Patients with Previous Diagnosis of Multiple Myeloma (MM).

Sumit Madan, M.D., Angela Dispenzieri, M.D., Martha Q. Lacy, MD, Francis Buadi, M.D., Suzanne R. Hayman, MD, Kristin Detweiler, R.N., C.N.P, Steven R. Zeldenrust, M.D., Ph.D., David Dingli, M.D., PhD., Philip R Greipp, M.D., Stephen J. Russell, MD, PhD, John A. Lust, MD, PhD, Robert A Kyle, MD, S. Vincent Rajkumar, M.D., Morie A Gertz, M.D., Shaji K Kumar, MD

Blood (2009) 114 (22): 4867.

https://doi.org/10.1182/blood.V114.22.4867.4867

Published: 2009

Journal Articles

Retrospective Study of the Efficacy of Bortezomib in Primary Systemic Amyloidosis.

Francis Buadi, MD, Martha Q. Lacy, MD, Angela Dispenzieri, M.D., Shaji Kumar, Suzanne Hayman, MD, Kristen E Detweiler Short, R.N., C.N.P., David Dingli, M.D., PhD., Steven R. Zeldenrust, M.D., Ph.D., Philip R. Greipp, MD, John A. Lust, MD, PhD, Stephen J. Russell, MD, PhD, Robert Kyle, M.D., Vincent Rajkumar, MD, Morie A Gertz, MD

Blood (2009) 114 (22): 4953.

https://doi.org/10.1182/blood.V114.22.4953.4953

Published: 2009

Journal Articles

Melphalan and Prednisone (MP) Versus Melphalan, Prednisone and Thalidomide (MPT) as Initial Therapy for Previously Untreated Elderly and/or Transplant Ineligible Patients with Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials.

Prashant Kapoor, MD, S. Vincent Rajkumar, MD, Angela Dispenzieri, MD, Martha Q. Lacy, MD, David Dingli, M.D., PhD., Robert Kyle, M.D., Morie A. Gertz, MD, Philip . R Greipp, MD, Shaji Kumar, MD, Sumithra J. Mandrekar, PhD

Blood (2009) 114 (22): 615.

https://doi.org/10.1182/blood.V114.22.615.615

Published: 2009

Journal Articles

Outcomes with High Dose Therapy and Peripheral Blood Stem Cell Transplantation for Light Chain (AL) Amyloidosis with Cardiac Involvement.

Sumit Madan, M.D., Shaji Kumar, M.D., Angela Dispenzieri, MD, Martha Q. Lacy, MD, Suzanne Hayman, MD, Francis Buadi, MD, David Dingli, M.D., PhD., Morie A Gertz, MD

Blood (2009) 114 (22): 534.

https://doi.org/10.1182/blood.V114.22.534.534

Published: 2009

NARROW

Evidence for Cytogenetic and Fluorescence in Situ Hybridization (FISH) Risk Stratification of Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies.

Isolated Trisomy 8 in the Myelodysplastic Syndromes.

A Risk Adapted Approach Utilizing Plerixafor in Autologous Peripheral Blood Stem Cell Mobilization.

Predicting Poor Peripheral Blood Stem Cell Mobilization in Multiple Myeloma (MM) Using Initial Peripheral CD34 Counts: Developing Target-Based Cut-Points for Early Intervention.

Asymptomatic Amyloidosis at the Time of Diagnostic Bone Marrow Biopsy in Newly Diagnosed Patients with Multiple Myeloma and Smoldering Multiple Myeloma.

A Phase II Trial of Lenalidomide, Cyclophosphamide and Dexamethasone (RCD) in Patients with Light Chain Amyloidosis.

Engineering VSV-IFN-NIS for the Treatment of Multiple Myeloma.

Clinical Features and Treatment Response of Light Chain (AL) Amyloidosis Diagnosed in Patients with Previous Diagnosis of Multiple Myeloma (MM).

Retrospective Study of the Efficacy of Bortezomib in Primary Systemic Amyloidosis.

Melphalan and Prednisone (MP) Versus Melphalan, Prednisone and Thalidomide (MPT) as Initial Therapy for Previously Untreated Elderly and/or Transplant Ineligible Patients with Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials.

Outcomes with High Dose Therapy and Peripheral Blood Stem Cell Transplantation for Light Chain (AL) Amyloidosis with Cardiac Involvement.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only